Filing Flows › PAVmed (PAVM) › Q1 2026 › vs Q4 2025
PAVmed (PAVM) Q1 2026 vs Q4 2025 (quarter over quarter)
PAVmed's revenue fell $30K (-58%) from $52K in Q4 2025 to $22K in Q1 2026.
PAVmed, Q1 2026: revenue $22K (+175% year over year), net loss $1.1M, operating cash flow −$2.6M. The chart draws each line against Q4 2025, the increases inside each band.
Every line
| Line | Q1 2026 | Q4 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $22K | $52K | −$30K | -58% |
| Other income, net | $7.0M | $4.0M | $2.9M | +72% |
| Net loss | $1.1M | $2.8M | −$1.7M | -61% |
| Costs & expenses | $8.1M | $6.9M | $1.2M | +18% |
| Operating costs | $8.1M | $6.9M | $1.2M | +18% |
| Cost of revenue | $97K | $85K | $12K | +14% |
| Research & development | $1.4M | $1.8M | −$440K | -24% |
| Sales & marketing | $216K | $249K | −$33K | -13% |
| General & admin | $6.4M | $4.7M | $1.7M | +35% |
| Operating cash sources | $2.8M | $1.8M | $1.0M | +57% |
| Depreciation & amortization | $20K | $18K | $2K | +11% |
| Share-based compensation | $182K | $232K | −$50K | -22% |
| Cash used in operations | $2.6M | $1.6M | $1.1M | +69% |
| Net loss absorbed | $1.1M | $2.8M | −$1.7M | -61% |
| Working capital & other | $1.8M | −$956K | $2.7M | — |
Questions
How much did PAVmed's revenue grow quarter over quarter in Q1 2026?
PAVmed's revenue fell $30K (-58%) from $52K in Q4 2025 to $22K in Q1 2026.